stomach cancer

AZ/Daiichi Sankyo’s Enhertu gets second US cancer indication
AZ/Daiichi Sankyo’s Enhertu gets second US cancer indication
Pharmaforum
AstraZeneca
Daiichi Sankyo
stomach cancer
Enhertu
Roche
Herceptin
Flag link:
Why Five Prime Therapeutics Stock Gained 312% in November
Why Five Prime Therapeutics Stock Gained 312% in November
Motley Fool
Five Prime Therapeutics
stomach cancer
bemarituzumab
Flag link:
Five Prime looks to turn a corner
Five Prime looks to turn a corner
EP Vantage
Five Prime Therapeutics
stomach cancer
bemarituzumab
Flag link:
ASCO data back AZ/Daiichi Sankyo’s Enhertu in new HER2 cancers
ASCO data back AZ/Daiichi Sankyo’s Enhertu in new HER2 cancers
Pharmaforum
Daiichi Sankyo
AstraZeneca
Enhertu
stomach cancer
colorectal cancer
lung cancer
ASCO 2020
Flag link:
Blueprint gets first approval as FDA backs stomach cancer drug
Blueprint gets first approval as FDA backs stomach cancer drug
Pharmaforum
Blueprint Medicines
FDA
Ayvakit
stomach cancer
Flag link:
One of Merck’s pivotal stomach cancer trials for Keytruda flops, just months after an FDA OK
One of Merck’s pivotal stomach cancer trials for Keytruda flops, just months after an FDA OK
Endpoints
Merck
Keytruda
stomach cancer
clinical trials
Flag link:
Lilly Nixes Expansion of Stomach Cancer Drug After Mixed Study Results
Lilly Nixes Expansion of Stomach Cancer Drug After Mixed Study Results
Xconomy
Eli Lilly
stomach cancer
Cyramza
Flag link:
Merck's Keytruda resumes regulatory hot streak with stomach cancer approval
Merck's Keytruda resumes regulatory hot streak with stomach cancer approval
Fierce Pharma
Merck
Keytruda
stomach cancer
Flag link:
Bristol-Myers' Opdivo succeeds in key stomach cancer study
Bristol-Myers' Opdivo succeeds in key stomach cancer study
Yahoo/Reuters
Bristol-Myers Squibb
Opdivo
stomach cancer
Flag link:
A Novel, Targeted Drug Yields Promising Results In Stomach And Esophageal Cancer
A Novel, Targeted Drug Yields Promising Results In Stomach And Esophageal Cancer
Forbes
ASCO 2016
Claudiximab
antibodies
Ganymed
stomach cancer
esophageal cancer
Flag link:
Amgen scraps trials of drug for advanced stomach cancer
Amgen scraps trials of drug for advanced stomach cancer
Yahoo/Reuters
Amgen
stomach cancer
rilotumumab
Flag link:
Lilly gains new stomach cancer approval for Cyramza
Lilly gains new stomach cancer approval for Cyramza
Pharmaphorum
Eli Lilly
stomach cancer
Cyramza
FDA
Flag link:
Merck KGaA Says Erbitux Fails In Stomach Cancer Trial
Merck KGaA Says Erbitux Fails In Stomach Cancer Trial
Bloomberg
Erbitux
stomach cancer
Merck KGaA
Flag link:
US FDA backs Roche's Herceptin in stomach cancer
US FDA backs Roche's Herceptin in stomach cancer
Reuters, UK
FDA
Roche
Herceptin
stomach cancer
Flag link:
Popular Bone Drugs Don't Raise Esophageal, Stomach Tumor Risk, Study Finds
Popular Bone Drugs Don't Raise Esophageal, Stomach Tumor Risk, Study Finds
Bloomberg
stomach cancer
New England Journal of Medicine
osteoporosis
Roche
Boniva
Merck
Fosamax
Flag link:
Roche files new Herceptin use for US approval
Roche files new Herceptin use for US approval
Reuters
Roche
Herceptin
stomach cancer
Flag link:
Avastin fails stomach-cancer trial
Avastin fails stomach-cancer trial
Fierce Pharma
Avastin
stomach cancer
Roche
Flag link:
ASCO: New Research on Breast, Stomach and Lung Cancers
ASCO: New Research on Breast, Stomach and Lung Cancers
WSJ Online
breast cancer
cancer ASCO
Roche
stomach cancer
lung cancer
Flag link:
Roche’s Herceptin Fights Stomach Cancer in Those With Gene
Roche’s Herceptin Fights Stomach Cancer in Those With Gene
Bloomberg
Roche
Herceptin
stomach cancer
Flag link:
Genentech reports Herceptin effective for stomach cancer
Genentech reports Herceptin effective for stomach cancer
Marketwatch
Genentech
Herceptin
Roche
stomach cancer
Flag link: